Diurnal Renames Orphan Drug As Efmody, Expecting EU-Wide Approval
EMA Also OKs Novel Contraceptive With Blockbuster Potential
Executive Summary
New treatments for congenital adrenal hyperplasia and relapsing forms of multiple sclerosis are among five drugs recommended for pan-EU approval this month. In addition, harmonized EU advice has been issued for Celltrion’s monoclonal antibody COVID-19 treatment.